Tenvir L

Product Description

Tenvir L Tablet is an antiretroviral medication combining the active ingredients Lamivudine and Tenofovir. Produced by Cipla Ltd., this prescription drug is primarily indicated for the treatment of HIV (Human Immunodeficiency Virus) and hepatitis B virus (HBV) infections. The medication is formulated as oral tablets for convenient administration.

Uses

Tenvir L Tablet is clinically approved for managing HIV infection and chronic hepatitis B. As an antiretroviral agent, it effectively inhibits viral replication in the body. This medication is typically prescribed as part of combination antiretroviral therapy (ART) regimens for optimal treatment outcomes.

How to Use

This medication should be taken exactly as prescribed by your healthcare provider. The standard dosage regimen involves taking one tablet daily, with or without food. For optimal therapeutic effect, maintain consistent dosing times daily. Never adjust your dosage or discontinue treatment without medical supervision. If a dose is missed, take it promptly unless it’s nearly time for the next scheduled dose, in which case skip the missed dose and resume your regular schedule.

How it Works

Tenvir L Tablet exerts its therapeutic effect by inhibiting essential viral enzymes required for HIV and HBV replication. Both Lamivudine and Tenofovir function as nucleoside reverse transcriptase inhibitors (NRTIs), specifically targeting and blocking the reverse transcriptase enzyme. This mechanism prevents viral multiplication, thereby reducing viral load and slowing disease progression.

Benefits

Tenvir L Tablet offers significant clinical benefits including retardation of HIV progression and reduction of HIV-associated complications such as opportunistic infections and malignancies. For HBV patients, the medication effectively lowers viral load, potentially slowing liver disease progression. This treatment can significantly enhance patients’ quality of life and improve long-term survival rates.

Common Side Effects

Patients may experience mild to moderate adverse effects including cephalalgia, nausea, diarrhea, sleep disturbances, and fatigue. Some individuals may develop dermatological reactions, vertigo, or alterations in adipose tissue distribution. While most side effects are transient, serious conditions such as lactic acidosis and hepatic impairment require immediate medical intervention.

Dosage and Administration

The standard adult dosage for HIV/HBV treatment is one Tenvir L Tablet administered orally once daily. Consistent daily administration at the same time is crucial for maintaining therapeutic drug levels. Dosage adjustments may be necessary based on renal function, comorbidities, and individual treatment response.

Warnings

Exercise caution when prescribing Tenvir L Tablet to patients with renal impairment, hepatic dysfunction, or bone disorders. The medication carries a risk of lactic acidosis – patients experiencing symptoms including profound fatigue, myalgia, respiratory distress, abdominal pain, nausea/vomiting, peripheral cyanosis, or cardiac arrhythmias should seek urgent medical care. Pregnancy status and breastfeeding considerations should be discussed with healthcare providers before initiating therapy.

Storage

Maintain Tenvir L Tablets at controlled room temperature (15-30°C), protected from light and humidity. Store in child-resistant containers out of children’s reach. Discard any medication beyond the expiration date indicated on the packaging.